
Quarterly report 2025-Q3
added 11-06-2025
HealthStream Financial Ratios 2011-2026 | HSTM
Annual Financial Ratios HealthStream
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
50.7 | 54.9 | 64.8 | 142.2 | 49.5 | 52.3 | 24.9 | 72.2 | 181.5 | 73.2 | 71.9 | 90.2 | 81.1 | 56.3 |
P/S |
3.5 | 3.0 | 2.9 | 3.2 | 2.9 | 3.2 | 3.5 | 2.9 | 3.0 | 3.0 | 4.4 | 5.7 | 6.0 | 4.8 |
EPS |
0.7 | 0.5 | 0.4 | 0.2 | 0.4 | 0.5 | 1 | 0.3 | 0.1 | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 |
EV (Enterprise Value) |
955 M | 794 M | 737 M | 784 M | 661 M | 845 M | 790 M | 748 M | 742 M | 649 M | 755 M | 763 M | 621 M | 347 M |
EBITDA per Share |
2.06 | 1.87 | 1.64 | 1.42 | 1.44 | 1.32 | 1.23 | 1.13 | 0.876 | 1.02 | 0.99 | 0.839 | 0.77 | 0.746 |
EV/EBITDA |
17.2 | 15.6 | 16.3 | 16.8 | 17.7 | 22.8 | 18.0 | 24.4 | 31.1 | 28.8 | 18.8 | |||
PEG |
5.31 | 6.17 | 8.28 | 13.42 | 6.12 | -1.02 | 0.11 | 0.44 | -3.07 | -3.09 | 3.18 | 13.08 | -12.58 | 0.89 |
P/B |
2.0 | 1.7 | 1.6 | 1.7 | 1.4 | 2.4 | 2.5 | 2.4 | 2.4 | 2.3 | 4.5 | 5.1 | 4.7 | 3.2 |
P/CF |
17.6 | 13.0 | 15.3 | 19.6 | 19.5 | 28.3 | 32.3 | 25.0 | 72.3 | 32.3 | 31.1 | 43.2 | 45.1 | 40.8 |
ROE % |
5.57 | 4.46 | 3.62 | 1.72 | 4.22 | 4.66 | 10.10 | 3.33 | 1.31 | 3.08 | 6.19 | 5.63 | 5.78 | 5.74 |
ROA % |
3.92 | 3.04 | 2.43 | 1.20 | 2.82 | 3.22 | 7.29 | 2.43 | 0.95 | 2.27 | 4.04 | 3.96 | 4.38 | 4.50 |
ROCE % |
5.92 | 4.70 | 3.73 | 2.38 | 4.74 | 3.83 | 4.62 | 3.16 | 1.85 | 4.67 | 9.10 | 9.38 | 9.65 | 9.31 |
Current Ratio |
- | - | - | - | - | 2.1 | 2.3 | 2.0 | 1.9 | 2.4 | 2.3 | 2.6 | 3.4 | 3.4 |
DSO |
40.4 | 46.5 | 45.9 | 50.5 | 51.0 | 43.6 | 64.6 | 64.0 | 76.5 | 67.0 | 74.5 | 73.7 | 58.1 | 77.1 |
DPO |
26.3 | 28.3 | 24.9 | 29.0 | 28.9 | 16.9 | 32.3 | 16.7 | 11.8 | 18.8 | 23.4 | 15.2 | 9.3 | 30.4 |
Operating Cycle |
40.4 | 46.5 | 45.9 | 50.5 | 51.0 | 43.6 | 64.6 | 64.0 | 76.5 | 67.0 | 74.5 | 73.7 | 58.1 | 77.1 |
Cash Conversion Cycle |
14.1 | 18.1 | 21.0 | 21.5 | 22.1 | 26.7 | 32.3 | 47.4 | 64.7 | 48.1 | 51.1 | 58.5 | 48.8 | 46.7 |
All numbers in USD currency
Quarterly Financial Ratios HealthStream
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.2 | 0.18 | 0.14 | - | 0.19 | 0.14 | 0.17 | - | 0.13 | 0.13 | 0.09 | - | 0.12 | 0.1 | 0.09 | - | 0.05 | 0.08 | 0.07 | - | 0.08 | 0.11 | 0.22 | - | 0.11 | 0.07 | 0.18 | - | 0.09 | 0.08 | 0.74 | - | 0.08 | 0.07 | 0.04 | - | 0.04 | 0.04 | 0.05 | - | 0.08 | 0.05 | 0.1 | - | 0.12 | 0.09 | 0.07 | - | 0.08 | 0.09 | 0.07 | - | 0.08 | 0.09 | 0.05 | - | 0.08 | 0.08 | 0.07 |
EBITDA per Share |
0.62 | 0.55 | 0.5 | - | 0.54 | 0.49 | 0.53 | - | 0.5 | 0.46 | 0.42 | - | 0.39 | 0.41 | 0.43 | - | 0.35 | 0.4 | 0.4 | - | 0.33 | 0.36 | 0.45 | - | 0.34 | 0.28 | 0.37 | - | 0.33 | 0.32 | 0.31 | - | 0.27 | 0.28 | 0.26 | - | 0.22 | 0.23 | 0.24 | 0.34 | 0.28 | 0.23 | 0.29 | - | 0.27 | 0.25 | 0.21 | - | 0.22 | 0.22 | 0.19 | - | 0.21 | 0.21 | 0.15 | - | 0.19 | 0.2 | 0.16 |
ROE % |
6.08 | 5.95 | 5.61 | 4.32 | 5.45 | 4.97 | 4.99 | 3.12 | 4.23 | 4.21 | 3.94 | 2.95 | 3.39 | 2.72 | 2.49 | 1.84 | 2.62 | 2.97 | 3.29 | 3.94 | 5.04 | 5.35 | 5.03 | 3.57 | 4.53 | 4.38 | 4.47 | 9.23 | 10.06 | 9.94 | 9.90 | 2.02 | 2.42 | 2.00 | 1.73 | 1.42 | 2.35 | 2.88 | 2.92 | 2.43 | 4.48 | 5.59 | 6.47 | 4.62 | 6.15 | 5.64 | 5.85 | 4.46 | 5.95 | 5.91 | 6.13 | 4.41 | 5.89 | 5.88 | 5.56 | 4.26 | 1.49 | 1.51 | 1.26 |
ROA % |
4.26 | 4.18 | 3.94 | 2.99 | 3.77 | 3.41 | 3.41 | 2.14 | 2.90 | 2.88 | 2.64 | 1.96 | 2.26 | 1.20 | 1.70 | 1.25 | 1.78 | 2.00 | 2.20 | 2.63 | 3.39 | 3.62 | 3.42 | 2.47 | 3.16 | 3.08 | 3.17 | 6.66 | 7.27 | 7.19 | 7.16 | 1.47 | 1.77 | 1.45 | 1.25 | 1.03 | 1.72 | 2.11 | 2.14 | 1.79 | 3.13 | 3.78 | 4.31 | 3.01 | 4.09 | 3.84 | 4.06 | 3.13 | 4.27 | 4.32 | 4.57 | 3.34 | 4.50 | 4.53 | 4.33 | 3.34 | 1.16 | 1.19 | 0.99 |
ROCE % |
6.88 | 6.54 | 6.13 | 4.74 | 6.16 | 5.75 | 5.67 | 3.46 | 4.18 | 3.48 | 3.21 | 2.88 | 3.40 | 3.20 | 3.30 | 2.51 | 3.45 | 3.86 | 4.14 | 4.39 | 5.50 | 5.67 | 5.06 | 3.37 | 4.83 | 5.18 | 5.85 | 3.97 | 4.88 | 4.33 | 3.92 | 2.63 | 3.08 | 2.62 | 2.50 | 2.13 | 3.67 | 4.76 | 4.87 | 4.17 | 6.99 | 8.27 | 9.81 | 7.24 | 9.83 | 9.60 | 9.90 | 7.47 | 10.29 | 10.52 | 10.82 | 7.65 | 9.88 | 9.28 | 8.80 | 6.91 | 2.23 | 2.57 | 2.11 |
DSO |
32.6 | 35.4 | 37.9 | - | 36.3 | 45.5 | 46.4 | - | 42.3 | 50.5 | 51.8 | - | 17.9 | 24.8 | 46.1 | - | 39.4 | 43.4 | 53.1 | - | 61.0 | 61.4 | 50.7 | - | 40.4 | 39.6 | 46.0 | - | 58.0 | 61.0 | 62.2 | - | 52.7 | 54.5 | 71.5 | - | 70.0 | 74.6 | 68.5 | - | 61.6 | 63.6 | 67.3 | - | 68.0 | 71.2 | 69.6 | - | 68.6 | 72.4 | 62.6 | - | 53.1 | 54.2 | 60.4 | - | 70.9 | 69.4 | - |
DPO |
13.7 | 12.5 | 17.6 | - | 19.1 | 21.4 | 23.7 | - | - | - | - | - | - | - | 10.6 | - | - | - | 18.7 | - | - | - | 10.8 | - | - | - | 14.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 16.4 | 12.3 | - | 8.9 | 9.5 | 17.4 | - | 29.8 | 30.9 | - |
Operating Cycle |
32.6 | 35.4 | 37.9 | - | 36.3 | 45.5 | 46.4 | - | 42.3 | 50.5 | 51.8 | - | 17.9 | 24.8 | 46.1 | - | 39.4 | 43.4 | 53.1 | - | 61.0 | 61.4 | 50.7 | - | 40.4 | 39.6 | 46.0 | - | 58.0 | 61.0 | 62.2 | - | 52.7 | 54.5 | 71.5 | - | 70.0 | 74.6 | 68.5 | - | 61.6 | 63.6 | 67.3 | - | 68.0 | 71.2 | 69.6 | - | 68.6 | 72.4 | 62.6 | - | 53.1 | 54.2 | 60.4 | - | 70.9 | 69.4 | - |
Cash Conversion Cycle |
18.9 | 22.9 | 20.4 | - | 17.2 | 24.2 | 22.7 | - | 42.3 | 50.5 | 51.8 | - | 17.9 | 24.8 | 35.5 | - | 39.4 | 43.4 | 34.4 | - | 61.0 | 61.4 | 39.9 | - | 40.4 | 39.6 | 31.6 | - | 58.0 | 61.0 | 62.2 | - | 52.7 | 54.5 | 71.5 | - | 70.0 | 74.6 | 68.5 | - | 61.6 | 63.6 | 67.3 | - | 68.0 | 71.2 | 69.6 | - | 68.6 | 56.0 | 50.3 | - | 44.2 | 44.7 | 43.1 | - | 41.1 | 38.5 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company HealthStream, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Health information services industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Accolade
ACCD
|
- | 0.29 % | $ 206 M | ||
|
Change Healthcare
CHNG
|
- | - | $ 9.03 B | ||
|
Phreesia
PHR
|
$ 11.2 | -0.8 % | $ 611 M | ||
|
Cerner Corporation
CERN
|
- | - | $ 27.9 B | ||
|
American Well Corporation
AMWL
|
$ 5.71 | -0.7 % | $ 91.6 M | ||
|
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
- | - | $ 2.94 B | ||
|
iCAD
ICAD
|
- | - | $ 102 M | ||
|
Schrödinger
SDGR
|
$ 11.42 | -1.3 % | $ 839 M | ||
|
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | ||
|
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | ||
|
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | ||
|
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | ||
|
Teladoc Health
TDOC
|
$ 5.59 | 3.23 % | $ 985 M | ||
|
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | ||
|
Premier
PINC
|
- | - | $ 2.33 B | ||
|
Omnicell
OMCL
|
$ 34.87 | 1.19 % | $ 1.61 B | ||
|
OptimizeRx Corporation
OPRX
|
$ 7.22 | 6.42 % | $ 124 M | ||
|
Evolent Health
EVH
|
$ 2.27 | 0.44 % | $ 213 M | ||
|
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | ||
|
GoodRx Holdings
GDRX
|
$ 2.06 | 0.98 % | $ 795 M | ||
|
SCWorx Corp.
WORX
|
$ 0.13 | 3.31 % | $ 190 K | ||
|
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | ||
|
R1 RCM
RCM
|
- | - | $ 3.81 B | ||
|
Akerna Corp.
KERN
|
- | - | $ 161 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | ||
|
Zhongchao
ZCMD
|
$ 1.85 | 2.16 % | $ 9.63 M | ||
|
Health Catalyst
HCAT
|
$ 1.1 | - | $ 76.9 M | ||
|
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | ||
|
HealthEquity
HQY
|
$ 82.18 | 0.1 % | $ 7.08 B | ||
|
10x Genomics
TXG
|
$ 20.69 | 4.42 % | $ 2.42 B | ||
|
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | ||
|
Progyny
PGNY
|
$ 17.8 | -1.41 % | $ 1.53 B | ||
|
So-Young International
SY
|
$ 3.15 | 8.08 % | $ 250 M | ||
|
Veeva Systems
VEEV
|
$ 178.12 | -0.56 % | $ 29.2 B |